|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
This article looks at what life science companies can do to ensure that compliance activities do not become a bottleneck when production constraints are removed.
Today's Context
The race to get more new drugs to market faster continues. This race is a team event and all areas of the business must be part of the team. Discover more; prove more; get more NDAs; create a larger market; get the product flowing reliably into the marketplace - and all faster than before.
The reorganisation of businesses, both in response to and in anticipation of change, presents the opportunity to create the right processes with the right performance. This is significant to all pharmaceutical processes, given the volume of data, the need for good information in the right place at the right time, and the imperative of data security. When a world-leading ethical pharmaceutical company looked at the output of one of its factories, alarm bells began to ring.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
7th Annual Pharma Packaging and Labelling conference
17 September - 18 October 2008, Barcelona
7th Annual Pharma Packaging and Labelling conference will bring
together experts from leading pharma manufacturers to present case study driven
presentations on critical industry-wide issues.
Attending this event will give you an opportunity to discuss with fellow
packaging and labelling professionals and share your views on these important
matters.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
